Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Colorcon
US Army
Fuji
Farmers Insurance
Healthtrust
Dow
AstraZeneca

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090231

« Back to Dashboard

NDA 090231 describes PEG 3350 AND ELECTROLYTES, which is a drug marketed by Mylan and Novel Labs Inc and is included in three NDAs. It is available from two suppliers. Additional details are available on the PEG 3350 AND ELECTROLYTES profile page.

The generic ingredient in PEG 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
Suppliers and Packaging for NDA: 090231
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PEG 3350 AND ELECTROLYTES polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 090231 ANDA Novel Laboratories, Inc. 40032-090 N 40032-090-19

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT
Approval Date:Jun 1, 2009TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Deloitte
Julphar
McKesson
Express Scripts
US Army
Medtronic
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.